Wipro Partners with IISc’s CBR for AI-driven Health Behaviour Solutions

Wipro on Tuesday collaborated with the Centre for Brain Research (CBR) at the Indian Institute of Science (IISc), Bangalore for the solution of artificial intelligence-driven health behaviour. The partnership will harness the power of AI, machine learning, and big data analytics to develop new technologies for the prevention and management of long-term health disorders.

Key Takeaways from Wipro’s Collaboration:

  • Wipro to collaborate with IISc’s CBR in the solution of artificial intelligence-driven health behaviour.
  • The partnership will harness the power of AI, machine learning, and big data analytics to develop new technologies for the prevention and management of long-term health disorders.

Wipro's research and development (R&D) department will design and develop a personal care engine that will consider an individual's health history, and desired health state. It will also design and develop behavioural responses to promote healthy ageing, positive lifestyle changes, and psychosocial well-being, to improve individual health over time.

Further, this personal care engine will reduce and manage the risk of cardiovascular disease and related neurodegenerative disorders by personalising interactions with users to optimise their long-term health and well-being.

About Wipro Limited:

Wipro Limited is a leading technology services and consulting company that focuses on building innovative solutions to address clients’ most complex digital transformation needs. It leverages the overall portfolio of capabilities in consulting, design, engineering, and operations. The company helps clients realise their boldest ambitions and build future-ready, sustainable businesses. The company has a footprint across 65 countries with over 230,000 employees and business partners.

Read More About Wipro Limited Share Price Here!

Top stories
Company

L&T Partners with PS Technology to Revolutionise Railways

6 mins read . 02 Aug 2024 . 12:45 PM

Company

Jindal Saw Q1 FY24 PAT Rises 67% to Rs 441 Cr

4 mins read . 02 Aug 2024 . 12:41 PM

Company

Pfizer Q1 FY25 PAT Zooms 61% to Rs 151 Cr

4 mins read . 02 Aug 2024 . 12:36 PM

Related Blogs
blog-logo

Share Market

blog-logo

10 mins read . 09 Dec 2024

What is the Bombay Stock Exchange?

  • 0 people read
blog-logo

Share Market

blog-logo

13 mins read . 09 Dec 2024

Stocks Under 5 Rupees in India

  • 0 people read
Kickstart your equities journey today You've got this
By submitting this I agree to the terms & conditions